According to Viking Therapeutics 's latest financial reports and stock price the company's current number of shares outstanding is 103,457,305. At the end of 2024 the company had 103,457,305 shares outstanding. The number of outstanding shares is usually impacted by stock plits and shares buy back.
Year | Shares Outstanding | Change |
---|---|---|
2024 | 0.10 B | 3.62% |
2023 | 99.84 M | 30.37% |
2022 | 76.58 M | -0.42% |
2021 | 76.9 M | 5.5% |
2020 | 72.89 M | 1.19% |
2019 | 72.04 M | 0.98% |
2018 | 71.34 M | 138.82% |
2017 | 29.87 M | 49.88% |
2016 | 19.93 M | 121.13% |
2015 | 9.01 M | 109.12% |
2014 | 4.3 M | -48.78% |
2013 | 8.41 M | 95.24% |
2012 | 4.3 M |
Company | Shares Outstanding | differencediff. | Country |
---|---|---|---|
Ultragenyx RARE | 71,664,493 | -30.73% | ๐บ๐ธ USA |
Repligen
RGEN | 55,815,666 | -46.05% | ๐บ๐ธ USA |
Recro Pharma
REPH | 23,565,700 | -77.22% | ๐บ๐ธ USA |